# Pilot Study on the Efficacy and Safety of FIBRORESTIL® as an Adjuvant Intralesional Treatment in Patients With Peyronie's Disease Receiving Standard Therapy

> **NCT07341529** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Lyx Institute** · enrollment: 38 (actual)

## Conditions studied

- Peyronie Disease

## Interventions

- **DEVICE:** Intralesional hyaluronic acid-based enzymatic medical device
- **OTHER:** Standard conservative treatment for Peyronie's disease

## Key facts

- **NCT ID:** NCT07341529
- **Lead sponsor:** Lyx Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-15
- **Primary completion:** 2026-03-15
- **Final completion:** 2026-05-15
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2026-01-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07341529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07341529, "Pilot Study on the Efficacy and Safety of FIBRORESTIL® as an Adjuvant Intralesional Treatment in Patients With Peyronie's Disease Receiving Standard Therapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07341529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*